ArticleAll life2022

Genome scale CRISPR Cas9a knockout screen reveals genes that control glioblastoma susceptibility to the alkylating agent temozolomide.

Chidiebere U Awah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.